main content start

Homepage

Our Login / Registration service is temporarily unavailable, due to technical issue.

Latest Videos

Latest Videos

Breast Cancer

Prostate Cancer

Multiple Myeloma

Multiple Myeloma

Brightcove Cards Listing

Popular on MedEnrich

Popular in No name
  • Breast Cancer8m 46s

    Expert Perspective - How I Treat Metastatic Her2 Positive Breast Cancer

    Anti-HER2 directed therapy remains the cornerstone of care for individuals with HER2-positive metastatic breast cancer (MBC).
    anti-her2 directed therapy her2-positive metastatic breast cancer expert perspective algorithm for management of her2 positive mbc
  • Prostate Cancer49m 18s

    Dissecting the biology of advanced prostate cancer

    Advanced prostate cancer is characterized by intricate biological changes, including genetic and epigenetic alterations, as well as shifts in cellular metabolism.
    advanced prostate cancer cellular metabolism castration-resistant prostate cancer targeted therapies improved patient care
  • Breast Cancer3m 2s

    ESR1 Mutation as an emerging clinical biomarker metastatic hormone receptor positive Breast Cancer

    Combination of CDK4/6 inhibitors & aromatase inhibitor is recommended for frontline treatment of Hormone receptor positive (ER+ve) Metastatic Breast Cancer. Patients eventually develop disease progression which might be attributed to ESR1 mutations.
    biomarkers esr1 mutation fulvestrant hormone receptor positive mbc serd
  • Breast Cancer14m 46s

    ESMO 2022 Breast Cancer Comprehensive Coverage

    View comprehensive coverage of Breast Cancer from ESMO 2022
    dose dense adjuvant chemotherapy esmo keynote -522 monarch -3 study
  • Oncology3m 36s

    Tissue Agnostic Treatment options in Solid Tumors

    Tissue-agnostic treatment based on shared genetic aberrations have provided a new direction in cancer treatment. Emerging clinical evidence indicates that many molecular aberrations can be common across tumor types with different site of origin.
    personalized medicine precision medicine tissue agnostic treatment
  • Multiple Myeloma8m 2s

    EHA 2022 Updates : Multiple Myeloma

    EHA 2022 saw exciting progress particularly from the perspective of Bispecific Antibodies showing encouraging response rates in relapsed / refractory setting of Multiple Myeloma.
    bcma targeting bispecific antibodies pneumocystis jirovecii pneumonia
  • Multiple Myeloma3m 16s

    Need of Geriatric assessment in Multiple Myeloma

    Majority of Myeloma patients are > 65 years of age at diagnosis & that makes Geriatric Assessment a critical for these patients. Historically we have focused on Cytogenetic & Biochemical evaluation but not so much on geriatric assessment.
    geriatric assessment multiple myeloma quality of life
  • OncoSpecials6m 24s

    2nd Genenration TKIs for 1st line CP-CML -Selecting Right Patients

    Deep Molecular Responses (DMR) in CML can protect from progression.2nd generation TKIs are associated with higher rates of DMR than 1st generation TKIs.
    2nd generation tki deep molecular response elts high risk e14a2 transcripts
  • Prostate Cancer7m 6s

    Treating Metastatic Hormone Refractory Prostate Cancer - My Approach

    Revised definition of Castration Resistant Prostate Cancer (mCRPC) considers castration range testosterone with either biochemical progression with three consecutive rises in PSA or evidence of radiological progression.
    castration resistance mcrpc metastatic prostate cancer prostate cancer
  • Breast Cancer1m 21s

    Recent advances in triple-negative breast cancer (TNBC)

    Metastatic Triple Negative Breast Cancer is still an unmet medical need.
    germline brca mutation pdl1 triple negative breast cancer
  • For Pharmacist

    For Pharmacist

    Brightcove Cards Listing

    Webinars

    Webinar Cards Listing

    Upcoming Webinar

    Upcoming Webinar

    MedBytes

    MedBytes

    Medbytes Cards Listing
    Hi, can I help?
    Chat SupportX
    Support Team
    Hello, how can I help you today?
    Please select one of the below options.

    Find Information

    Unable to Login or Register

    Want to share feedback